<SEC-DOCUMENT>0001628280-25-048251.txt : 20251103
<SEC-HEADER>0001628280-25-048251.hdr.sgml : 20251103
<ACCEPTANCE-DATETIME>20251103161523
ACCESSION NUMBER:		0001628280-25-048251
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20251103
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251103
DATE AS OF CHANGE:		20251103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDIFAST INC
		CENTRAL INDEX KEY:			0000910329
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				133714405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31573
		FILM NUMBER:		251444282

	BUSINESS ADDRESS:	
		STREET 1:		100 INTERNATIONAL DRIVE
		STREET 2:		18TH FLOOR
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21202
		BUSINESS PHONE:		4105818042

	MAIL ADDRESS:	
		STREET 1:		100 INTERNATIONAL DRIVE
		STREET 2:		18TH FLOOR
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHRITE INC
		DATE OF NAME CHANGE:	19951120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XX
		DATE OF NAME CHANGE:	19950619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	00
		DATE OF NAME CHANGE:	19950619
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>med-20251103.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:97c59a06-5bc4-4c26-acc3-1076f581d176,g:d5fc315c-c4d9-4f71-a231-812f84c7672f,d:569f3f87a6954b798dddad13c9384939-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>med-20251103</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0000910329</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="med-20251103.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-11-03</xbrli:startDate><xbrli:endDate>2025-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-11-03</xbrli:startDate><xbrli:endDate>2025-11-03</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i569f3f87a6954b798dddad13c9384939_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">The Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported):&#160;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">November 3, 2025</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">MEDIFAST, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(State or other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">jurisdiction of incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-31573</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">13-3714405</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">100 International Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Baltimore</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">21202</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code:&#160;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">410</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">581-8042</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:40.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-13">Common Stock, par value $0.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-14">MED</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-15">New York Stock Exchange</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;General Instruction A.2. below):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.199%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-18">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-19">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2).</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:96.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:324pt;text-align:right;text-indent:-324pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div id="i569f3f87a6954b798dddad13c9384939_7"></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02.&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On November 3, 2025, Medifast, Inc. (the "Company") issued a press release announcing its earnings for the third quarter ended September 30, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A copy of the Press Release is being furnished as Exhibit 99.1 attached hereto and is incorporated by reference herein. This information is being furnished in this report and shall not be deemed to be "filed" for any purpose, including for the purpose of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1993, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</span></div><div id="i569f3f87a6954b798dddad13c9384939_10"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:83.404%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(d)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibits.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="medq32025earningsrelease.htm">Medifast Announces Third Quarter 2025 Financial Results </a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL Document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i569f3f87a6954b798dddad13c9384939_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Signature</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.708%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">MEDIFAST, INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James P. Maloney</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">James P. Maloney</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dated: November 3, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>medq32025earningsrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="id8ad44e81ad540678a0e1bb75f8375fc_1"></div><div style="min-height:82.08pt;width:100%"><div><img alt="image_3a.jpg" src="image_3a.jpg" style="height:43px;margin-bottom:5pt;vertical-align:text-bottom;width:125px"></div><div><font><br></font></div></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:125%">Medifast Announces Third Quarter 2025 Financial Results </font></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">November&#160;3, 2025</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BALTIMORE &#8211; (BUSINESS WIRE) &#8212; Medifast (NYSE&#58; MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended September&#160;30, 2025.</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Third Quarter 2025</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:12.53pt">Revenue&#58; $89.4 million, with revenue per active earning coach of $4,585</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:12.53pt">Active Coaches&#58; Independent active earning</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA&#174; coaches of 19,500</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:12.53pt">Net Loss&#58; $2.3 million or $0.21 loss per diluted share</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:12.53pt">Strong Balance Sheet&#58; $173.5 million in cash, cash equivalents, and investment securities with no debt</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8220;We&#8217;re transforming Medifast from a weight-loss company into a leader in promoting metabolic health,&#8221; said Dan Chard, Chairman and Chief Executive Officer of Medifast. &#8220;Our clinically proven, coach-guided system does more than help people lose weight&#8212;it addresses the underlying metabolic dysfunction that drives most health challenges. This strategic evolution positions us in a larger, more durable market with strong consumer tailwinds. It&#8217;s a transformation founded in proven science that creates meaningful health outcomes.&#8221;</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Chard concluded, &#8220;With a strong balance sheet, a passionate coach community, and clinically proven plans, we believe Medifast is well positioned to become the trusted partner for millions seeking metabolic health.&#34;</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Third Quarter 2025 Results</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Third quarter 2025 revenue decreased 36.2% to $89.4 million from $140.2 million for the third quarter of 2024 primarily driven by a decrease in the number of active earning </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA coaches. The total number of active earning </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA coaches decreased 35.0% to 19,500 compared to 30,000 for the third quarter of 2024. The number of active earning </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA coaches has been trending downward year-over-year since the first quarter of 2023, driven by continued challenges with client acquisition due to the growing acceptance of GLP-1 medications for weight loss. The average revenue per active earning </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA coach was $4,585, compared to $4,672 for the third quarter last year, as the company experiences continued pressure with client acquisition associated with the rapid adoption of GLP-1 medications for weight loss. The company continues to see moderating year-over-year declines in this key metric.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gross profit decreased 41.2% to $62.2 million from $105.7 million for the third quarter of 2024. The decrease in gross profi</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">t was</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> due to lower revenue, partially offset by lower cost of sales. Gross profit margin was 69.5% compared to 75.4% in the third quarter of 2024, attributable to 450 basis points of loss of leverage on fixed costs and 180 basis points of reserve for the reformulation of the Essential product line.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Selling, general, and administrative expenses (&#8220;SG&#38;A&#8221;) decreased 36.0% to $66.2 million compared to $103.6 million for the third quarter of 2024. </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">decrease</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> in SG&#38;A wa</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">s primarily due to a $19.7 million decrease in coach compensation as a result of fewer active earning coaches and lower volumes. Additionally, SG&#38;A expenses in the third quarter of 2025 reflected decreases of $5.6 million related to company-led marketing compared to 2024, as well as $2.9 million for the company's convention costs, and $2.0 million for the company's collaboration with LifeMD, Inc. that did not recur in the third quarter of 2025. As a percentage of revenue, SG&#38;A increased 20 basis points year-over-year to 74.1% of revenue, as compared to 73.9% for the third quarter of 2024. The increase in SG&#38;A as a percentage of revenue was primarily due to 520 basis points associated with the loss of leverage on fixed costs and other smaller increases, partially offset by a 360 basis </font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div><img alt="image_3a.jpg" src="image_3a.jpg" style="height:43px;margin-bottom:5pt;vertical-align:text-bottom;width:125px"></div><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">point reduction related to company-led marketing, and 210 basis points for the company's convention costs incurred during the three months ended September 30, 2024, that did not recur in the third quarter of 2025.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company's loss from operations for the period was $4.1 million compared to income from operations of $2.1 million in the prior year comparable period. As a percentage of revenue, loss from operations was 4.6% for the third quarter of 2025 compared to income from operations of 1.5% in the prior-year period.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Other income increased approximately $2.0 million to $1.4 million compared to other expenses of $0.5 million for the third quarter of 2024. The increase in other income was primarily due to the absence of a loss on the company's investment in LifeMD, Inc. common stock that occurred during the corresponding period in 2024.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company recorded $0.4 million in income tax benefit, an effective tax rate of 14.9% for the third quarter of 2025, compared to $0.4 million in income tax expense, an effective tax rate of 28.5% in the prior-year period. The change in the effective tax rate for the three months ended September&#160;30, 2025 was primarily driven by a decrease in the tax benefit of research and development tax credits, which represented 115.3% of the change, partially offset by an increase of 85.6% from the impact of state taxes. These percentage changes were magnified by the near break-even pre-tax position in both periods.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In the third quarter of 2025, the company's net loss was $2.3 million, or $0.21 loss per diluted share, based on approximately 11.0</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> million shares </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">of common stock outstanding. In the third quarter of 2024, net income was $1.1 million, or $0.10 per diluted share, based on approximately 11.0</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> million shares</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> of common stock outstanding.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Capital Allocation and Balance Sheet</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company&#8217;s balance sheet remains strong with $173.5 million in cash, cash equivalents and investment securities and no debt as of September&#160;30, 2025, compared to $162.3 million in cash, cash equivalents and investment securities and no debt at December&#160;31, 2024.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Outlook</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company expects fourth quarter 2025 revenue to be in the range of $65 million to $80 million and fourth quarter 2025 diluted loss per share to be in the range of $0.70 to $1.25.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Conference Call Information</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The conference call is scheduled for today, Monday, November 3, 2025 at 4&#58;30 p.m. ET. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast&#8217;s website at </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">www.MedifastInc.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> or directly at https&#58;&#47;&#47;viavid.webcasts.com&#47;starthere.jsp&#63;ei&#61;1737984&#38;tp_key&#61;fe2490eae4 and will be archived online and available through February 3, 2026. In addition, listeners may dial (201) 389-0879 to join via telephone.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">A telephonic playback will be available from 8&#58;30 p.m. ET, November 3, 2025, through November 10, 2025. Participants can dial (412) 317-6671 and enter passcode 13756407 to hear the playback.</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">About&#160;Medifast</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:700;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">&#58;</font></div><div style="margin-top:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medifast (NYSE&#58; MED) is the health and wellness company known for its science-backed, coach-guided lifestyle system. Designed to help address the challenges of metabolic dysfunction, the company&#8217;s holistic approach integrates personalized plans, scientifically developed products and a framework for habit creation &#8212; all supported by a dedicated network of independent coaches. Driven to improve metabolic health through advanced science and comprehensive behavioral support, Medifast has introduced Metabolic Synchronization, a breakthrough science that reverses metabolic dysfunction through a targeted reset of the body&#8217;s metabolism. </font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div><img alt="image_3a.jpg" src="image_3a.jpg" style="height:43px;margin-bottom:5pt;vertical-align:text-bottom;width:125px"></div><div><font><br></font></div></div><div style="margin-top:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Research shows the company&#8217;s comprehensive system activates strong and targeted fat burn to enhance metabolic health and body composition by reducing visceral fat, preserving lean mass and protecting muscle. Backed by more than 40 years of clinical heritage, Medifast continues to advance its mission of Lifelong Transformation, Making Healthy Lifestyle Second Nature&#174;. For more information visit MedifastInc.com and follow Medifast on X and LinkedIn. </font></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MED-F</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Forward Looking Statements</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Please Note&#58; This release contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by use of phrases or terminology such as &#8220;intend,&#8221; &#8220;anticipate,&#8221; &#8220;expect&#8221; or other similar words or the negative of such terminology. Similarly, descriptions of Medifast&#8217;s objectives, strategies, plans, goals, outlook or targets contained herein are also considered forward-looking statements. These statements are based on the current expectations of the management of Medifast and are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Medifast's inability to maintain and grow the network of independent </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA coaches&#59; Industry competition and new weight loss products, including weight loss medications, or services&#59; Medifast&#8217;s health or advertising related claims by </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA clients&#59; Medifast's inability to continue to develop new products&#59; effectiveness of Medifast's advertising and marketing programs, including use of social media by </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA coaches&#59; the departure of one or more key personnel&#59; Medifast's inability to protect against online security risks and cyberattacks&#59; risks associated with Medifast's direct-to-consumer business model&#59; disruptions in Medifast's supply chain&#59; product liability claims&#59; Medifast's planned growth into domestic markets and transformation to promote metabolic health&#59; adverse publicity associated with Medifast's products&#59; the impact of existing and future laws and regulations on Medifast&#8217;s business&#59; fluctuations of Medifast's common stock market price&#59; increases in litigation&#59; actions of activist investors&#59; the consequences of other geopolitical events, overall economic and market conditions and the resulting impact on consumer sentiment and spending patterns&#59; and Medifast's ability to prevent or detect a failure of internal control over financial reporting. Although Medifast believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and other filings filed with the United States Securities and Exchange Commission, including its quarterly reports on Form 10-Q and current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Investor Contact&#58;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medifast, Inc.</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Steven Zenker</font></div><div><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">InvestorRelations&#64;medifastinc.com</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(443) 379-5256</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div><img alt="image_3a.jpg" src="image_3a.jpg" style="height:43px;margin-bottom:5pt;vertical-align:text-bottom;width:125px"></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except per share amounts &#38; dividend data)</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.994%"><tr><td style="width:1.0%"></td><td style="width:41.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.062%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended September 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Nine months ended September 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">2024</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">89,409</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">140,163</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">310,692</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">483,460</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Cost of sales</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">27,250</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">34,489</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">87,645</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">127,056</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Gross profit</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">62,159</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">105,674</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">223,047</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">356,404</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">66,240</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">103,568</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">229,457</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">354,235</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Income (loss) from operations</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">(4,081)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">2,106</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">(6,410)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">2,169</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Other income (expense)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Interest income</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">1,426</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">1,333</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">4,096</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">3,851</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Other income (expense)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">(2)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">(1,861)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">3,057</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">(3,508)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">1,424</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">(528)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">7,153</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">343</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Income (loss) before provision for income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">(2,657)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">1,578</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">743</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">2,512</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Provision (benefit) for income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">(396)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">449</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">1,296</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">1,222</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Net income (loss)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">(2,261)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">1,129</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">(553)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">1,290</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Earnings (loss) per share - basic</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">(0.21)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">0.10</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">(0.05)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">0.12</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Earnings (loss) per share - diluted</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">(0.21)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">0.10</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">(0.05)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">0.12</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Weighted average shares outstanding</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Basic</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">10,991</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">10,937</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">10,977</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">10,928</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Diluted</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">10,991</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">10,971</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">10,977</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">10,959</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div><img alt="image_3a.jpg" src="image_3a.jpg" style="height:43px;margin-bottom:5pt;vertical-align:text-bottom;width:125px"></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except par value)</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.546%"><tr><td style="width:1.0%"></td><td style="width:58.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">September 30,<br>2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">December 31,<br>2024</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">ASSETS</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Current Assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">99,526</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:-1.19pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">90,928</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Inventories, net</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">23,205</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">42,421</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Investments</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">73,986</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">71,416</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Income taxes, prepaid</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">4,300</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">6,821</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">9,639</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Total current assets</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">207,838</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">214,404</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Property, plant and equipment, net of accumulated depreciation</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">32,846</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">37,527</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">8,397</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">11,155</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Other assets</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">7,020</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">9,667</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Deferred tax assets, net</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">12,108</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">11,460</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">TOTAL ASSETS</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">268,209</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:-1.19pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">284,213</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">LIABILITIES AND STOCKHOLDERS' EQUITY</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Current Liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable and accrued expenses</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">41,242</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:-1.19pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">56,494</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Income taxes payable</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">1,485</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Current lease obligations</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">5,471</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">6,182</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Total current liabilities</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">46,713</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">64,161</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Lease obligations, net of current lease obligations</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">6,790</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">9,943</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Total liabilities</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">53,503</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">74,104</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Stockholders' Equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Common stock, par value $.001 per share&#58; 20,000 shares authorized&#59;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">10,991 and 10,938 issued and outstanding</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">at September 30, 2025 and December 31, 2024, respectively</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">11</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">11</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Additional paid-in capital</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">38,233</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">33,136</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">220</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">180</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">Retained earnings</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">176,242</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:114%">176,782</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">Total stockholders' equity</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">214,706</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">210,109</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt;text-indent:-1.19pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</font></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">268,209</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td colspan="2" style="border-bottom:3pt double #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:114%">284,213</font></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>med-20251103.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:97c59a06-5bc4-4c26-acc3-1076f581d176,g:d5fc315c-c4d9-4f71-a231-812f84c7672f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:med="http://www.medifast1.com/20251103" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.medifast1.com/20251103">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20251103_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20251103_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20251103_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.medifast1.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>med-20251103_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:97c59a06-5bc4-4c26-acc3-1076f581d176,g:d5fc315c-c4d9-4f71-a231-812f84c7672f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.medifast1.com/role/Cover" xlink:type="simple" xlink:href="med-20251103.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_5a5046ae-ad0c-4562-b07d-84dd7f806651" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntitiesTable_5a5046ae-ad0c-4562-b07d-84dd7f806651" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_d0c3b12c-f47d-4300-b159-60e43eaee647" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_5a5046ae-ad0c-4562-b07d-84dd7f806651" xlink:to="loc_dei_EntityListingsExchangeAxis_d0c3b12c-f47d-4300-b159-60e43eaee647" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_d0c3b12c-f47d-4300-b159-60e43eaee647_default" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_d0c3b12c-f47d-4300-b159-60e43eaee647" xlink:to="loc_dei_ExchangeDomain_d0c3b12c-f47d-4300-b159-60e43eaee647_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_79e3aefe-6c60-4e4c-b531-461378cbfa8d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_d0c3b12c-f47d-4300-b159-60e43eaee647" xlink:to="loc_dei_ExchangeDomain_79e3aefe-6c60-4e4c-b531-461378cbfa8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_7fcd5a8b-0986-4a4f-8338-ae0bec01348e" xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNYS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_79e3aefe-6c60-4e4c-b531-461378cbfa8d" xlink:to="loc_exch_XNYS_7fcd5a8b-0986-4a4f-8338-ae0bec01348e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4b1b1bab-844a-4326-8bb5-c66c0341af91" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_DocumentType_4b1b1bab-844a-4326-8bb5-c66c0341af91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4d65453d-9dbc-4711-89f2-1867bda54e26" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_DocumentPeriodEndDate_4d65453d-9dbc-4711-89f2-1867bda54e26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_cf27cb82-583d-4105-b2f6-bd49ead83ae5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityRegistrantName_cf27cb82-583d-4105-b2f6-bd49ead83ae5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7233e3eb-d5f0-4b0c-9c18-5cce19700ace" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityAddressAddressLine1_7233e3eb-d5f0-4b0c-9c18-5cce19700ace" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c0f020e3-7350-40ff-be89-028008953fc7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityAddressCityOrTown_c0f020e3-7350-40ff-be89-028008953fc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7ecb28fa-9c91-40e1-b4ab-ef44e26e5182" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityAddressStateOrProvince_7ecb28fa-9c91-40e1-b4ab-ef44e26e5182" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c2caccaf-e497-44ea-afd1-958b866cd9e9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityAddressPostalZipCode_c2caccaf-e497-44ea-afd1-958b866cd9e9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2a4cdc62-5087-495e-a249-901a65d9aa2a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_CityAreaCode_2a4cdc62-5087-495e-a249-901a65d9aa2a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_31dddc44-e98c-441b-8b2f-557705a94701" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_LocalPhoneNumber_31dddc44-e98c-441b-8b2f-557705a94701" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_90c231b6-7e1f-4612-ba3f-d5ba6b7ed7eb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_Security12bTitle_90c231b6-7e1f-4612-ba3f-d5ba6b7ed7eb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_af464888-1daf-42ac-8c98-e1af22d4732e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_TradingSymbol_af464888-1daf-42ac-8c98-e1af22d4732e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ea4ec561-5b65-4695-af9d-eebf56dea8f2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_SecurityExchangeName_ea4ec561-5b65-4695-af9d-eebf56dea8f2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_105f0438-e5e6-4d33-a968-6821aed890ca" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_WrittenCommunications_105f0438-e5e6-4d33-a968-6821aed890ca" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_b9576825-aa97-44a2-b87e-cbbaae186424" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_SolicitingMaterial_b9576825-aa97-44a2-b87e-cbbaae186424" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_708efe5d-b4a0-43e8-954a-e2eb346f7339" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_PreCommencementTenderOffer_708efe5d-b4a0-43e8-954a-e2eb346f7339" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_44cf1ec1-0160-4db0-82a4-f3743019003b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_44cf1ec1-0160-4db0-82a4-f3743019003b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c7f5b1b0-903d-4ec1-8ec7-e1ed7ebcbde0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityEmergingGrowthCompany_c7f5b1b0-903d-4ec1-8ec7-e1ed7ebcbde0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4257824e-7e9e-4180-9942-86e37b8c6d27" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityCentralIndexKey_4257824e-7e9e-4180-9942-86e37b8c6d27" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_308c9c84-f874-4552-8e5a-270f365ed257" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_AmendmentFlag_308c9c84-f874-4552-8e5a-270f365ed257" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_fc3457e6-2d6f-43d5-94de-61ae3c2c177d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityTaxIdentificationNumber_fc3457e6-2d6f-43d5-94de-61ae3c2c177d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a27336da-c14c-427d-97db-ed0386ab8769" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityFileNumber_a27336da-c14c-427d-97db-ed0386ab8769" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_211459b1-4885-40a8-9b48-c1c02d364666" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_211459b1-4885-40a8-9b48-c1c02d364666" xlink:type="arc" order="21"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>med-20251103_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:97c59a06-5bc4-4c26-acc3-1076f581d176,g:d5fc315c-c4d9-4f71-a231-812f84c7672f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_3de43571-3be8-4409-8203-49b42709d663_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_5337110d-79a3-4890-aa92-39487b9507a8_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_088de981-a649-4650-bc1d-70584e188a15_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_8b4d629c-d25d-4501-8bd9-ad4e98efa46e_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_6f7fb725-eeb0-43f1-bad7-b1f234786820_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_36a5a122-7814-4d4f-b5de-d4ee936e2fd0_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ad054091-4e83-4a29-bed9-e10c14961d95_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2cfd520d-9101-4486-b22f-4cc1a0e6c2bf_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_d9857364-efe8-490e-af5b-a61a2aa75fe1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_63fd2c9a-afb8-4987-bc54-724169001126_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_cd5eb883-2fbf-463f-a1d9-f25d9b4e91d4_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_b5b5e38d-d90c-4617-8ce8-8ce5fd53ef1a_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_78635f1f-822e-4b93-95d7-cdd7a8ed87d2_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_cb3fbddf-bdaa-48ce-87ef-9123d0457b1e_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_8dda459c-e730-4372-bad8-4655d2066be7_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_8483ab15-f51e-4747-9858-211b6357efe8_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_85a783ad-0b3c-4a4a-b2d9-f56290bc116f_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_c120c061-4264-407e-81bc-06eba0de76e8_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_f409df92-899b-4b5c-ac94-81527554be9c_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_7a22f6b0-51c4-43cf-9e33-9dbbeb711015_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_382330c2-23cd-4f20-9f6e-6aace1e4436e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d605b891-f6b6-45cf-b277-ae05bf84146d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f880b1ec-0623-4f4d-acc2-2bb7ca0542f0_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_4f0592e6-212f-47d3-a321-1cdf3c3ef78d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f7ebba29-4428-4022-bd48-8591c2a6dedd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNYS_e03d2517-b440-4590-bb88-ac55575eac58_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC.</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS" xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNYS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_320ddb0e-0576-47eb-8668-576c4a4a78f6_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>med-20251103_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:97c59a06-5bc4-4c26-acc3-1076f581d176,g:d5fc315c-c4d9-4f71-a231-812f84c7672f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medifast1.com/role/Cover" xlink:type="simple" xlink:href="med-20251103.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8c5e13bd-f3b5-4f41-8fe5-ff0822934c2e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_5a5046ae-ad0c-4562-b07d-84dd7f806651" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c5e13bd-f3b5-4f41-8fe5-ff0822934c2e" xlink:to="loc_dei_EntitiesTable_5a5046ae-ad0c-4562-b07d-84dd7f806651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_d0c3b12c-f47d-4300-b159-60e43eaee647" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_5a5046ae-ad0c-4562-b07d-84dd7f806651" xlink:to="loc_dei_EntityListingsExchangeAxis_d0c3b12c-f47d-4300-b159-60e43eaee647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_79e3aefe-6c60-4e4c-b531-461378cbfa8d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_d0c3b12c-f47d-4300-b159-60e43eaee647" xlink:to="loc_dei_ExchangeDomain_79e3aefe-6c60-4e4c-b531-461378cbfa8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_7fcd5a8b-0986-4a4f-8338-ae0bec01348e" xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNYS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_79e3aefe-6c60-4e4c-b531-461378cbfa8d" xlink:to="loc_exch_XNYS_7fcd5a8b-0986-4a4f-8338-ae0bec01348e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_5a5046ae-ad0c-4562-b07d-84dd7f806651" xlink:to="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4b1b1bab-844a-4326-8bb5-c66c0341af91" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_DocumentType_4b1b1bab-844a-4326-8bb5-c66c0341af91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4d65453d-9dbc-4711-89f2-1867bda54e26" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_DocumentPeriodEndDate_4d65453d-9dbc-4711-89f2-1867bda54e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_cf27cb82-583d-4105-b2f6-bd49ead83ae5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityRegistrantName_cf27cb82-583d-4105-b2f6-bd49ead83ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7233e3eb-d5f0-4b0c-9c18-5cce19700ace" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityAddressAddressLine1_7233e3eb-d5f0-4b0c-9c18-5cce19700ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c0f020e3-7350-40ff-be89-028008953fc7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityAddressCityOrTown_c0f020e3-7350-40ff-be89-028008953fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7ecb28fa-9c91-40e1-b4ab-ef44e26e5182" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityAddressStateOrProvince_7ecb28fa-9c91-40e1-b4ab-ef44e26e5182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c2caccaf-e497-44ea-afd1-958b866cd9e9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityAddressPostalZipCode_c2caccaf-e497-44ea-afd1-958b866cd9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2a4cdc62-5087-495e-a249-901a65d9aa2a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_CityAreaCode_2a4cdc62-5087-495e-a249-901a65d9aa2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_31dddc44-e98c-441b-8b2f-557705a94701" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_LocalPhoneNumber_31dddc44-e98c-441b-8b2f-557705a94701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_90c231b6-7e1f-4612-ba3f-d5ba6b7ed7eb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_Security12bTitle_90c231b6-7e1f-4612-ba3f-d5ba6b7ed7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_af464888-1daf-42ac-8c98-e1af22d4732e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_TradingSymbol_af464888-1daf-42ac-8c98-e1af22d4732e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ea4ec561-5b65-4695-af9d-eebf56dea8f2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_SecurityExchangeName_ea4ec561-5b65-4695-af9d-eebf56dea8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_105f0438-e5e6-4d33-a968-6821aed890ca" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_WrittenCommunications_105f0438-e5e6-4d33-a968-6821aed890ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_b9576825-aa97-44a2-b87e-cbbaae186424" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_SolicitingMaterial_b9576825-aa97-44a2-b87e-cbbaae186424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_708efe5d-b4a0-43e8-954a-e2eb346f7339" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_PreCommencementTenderOffer_708efe5d-b4a0-43e8-954a-e2eb346f7339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_44cf1ec1-0160-4db0-82a4-f3743019003b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_44cf1ec1-0160-4db0-82a4-f3743019003b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c7f5b1b0-903d-4ec1-8ec7-e1ed7ebcbde0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityEmergingGrowthCompany_c7f5b1b0-903d-4ec1-8ec7-e1ed7ebcbde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4257824e-7e9e-4180-9942-86e37b8c6d27" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityCentralIndexKey_4257824e-7e9e-4180-9942-86e37b8c6d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_308c9c84-f874-4552-8e5a-270f365ed257" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_AmendmentFlag_308c9c84-f874-4552-8e5a-270f365ed257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_fc3457e6-2d6f-43d5-94de-61ae3c2c177d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityTaxIdentificationNumber_fc3457e6-2d6f-43d5-94de-61ae3c2c177d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a27336da-c14c-427d-97db-ed0386ab8769" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityFileNumber_a27336da-c14c-427d-97db-ed0386ab8769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_211459b1-4885-40a8-9b48-c1c02d364666" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_56177756-9254-4582-af6b-8389ba4d22f6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_211459b1-4885-40a8-9b48-c1c02d364666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_3a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_3a.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MH\^6.A%V::/J[-<E\1/B)HGPK\*W7B+Q)>"PTNV*AI-I9F9C@*J@$DDGH/Y
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M7P;_ &=? GC3P_/I=W\/]-L3)J.E31#SY&>]D#'.W<!AUP58 <D@XY^F+CX
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M9;BGVJPN$FC##&1N4D9&1D9[US<GQ^^&L+,K^/O#*LI(*G6+<$$=1]^OG/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 03, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  03,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MEDIFAST, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 International Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Baltimore<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">21202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">581-8042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MED<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000910329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3714405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="med-20251103.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="med-20251103.htm">med-20251103.htm</File>
    <File>med-20251103.xsd</File>
    <File>med-20251103_def.xml</File>
    <File>med-20251103_lab.xml</File>
    <File>med-20251103_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "med-20251103.htm": {
   "nsprefix": "med",
   "nsuri": "http://www.medifast1.com/20251103",
   "dts": {
    "inline": {
     "local": [
      "med-20251103.htm"
     ]
    },
    "schema": {
     "local": [
      "med-20251103.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "med-20251103_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "med-20251103_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "med-20251103_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 28,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.medifast1.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "med-20251103.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "med-20251103.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitiesTable",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entities [Table]",
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information [Line Items]",
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Listings, Exchange [Axis]",
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange [Domain]",
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "exch_XNYS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2025",
     "localname": "XNYS",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NEW YORK STOCK EXCHANGE, INC.",
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001628280-25-048251-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-25-048251-xbrl.zip
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MN)>$;/8SFQN$AZ=&9+J.T;;AIPE\N<V3R@K59S1R!L8A1 /Q(::W!M'(/#4
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M/*8A^E<MFSA IFBCHH0OZPZM#IF.6S70A1)>ZR$ 4#)AZ/XHJ@-'J6@5;44
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MGO>H0_U:I/QMW/Q-/GWALKOC&3KMRR,N9M&Z.M.QL5]3B^8X9$$J5*JP-4D
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MZ48YQ?_,G6)U-?#]+%8$(2<5NG%/W3<!<<?VOQ3C^[1LU8&(2Y K"+OU05\
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M\7$$TL]U/QJM#/NCN&VI/X<;-;\/A-NF=A+8TM0-/_4H;L=?+O^Z&JLPDHC
M!'",0[UN3$/ .:5Z2DD(28C27ZT^>5M7/#):EV=_!G]]_/Q;<'7]\?2WX.S+
MZ:\?+G\Y>QV<7YZ^L6/KV7PW25Z6W+CI=!-\_5V9CV\.<'=_RTH'+Z;M ACS
MZ)F8YQJ#\+'5Y14-VS_PW^Q_K5\ZCE H)0\5"$D2ZYF@XH#&,07Z.V&VER0T
MLSXUO%GXR"2L=[P;+??]_+7U_5'B:\B- SLO7EOV-SO>:Z=^76CP#?J;W6_;
ME]_X^2X0-D?T0C]Z_VKU3+[XWS'>O_H_4$L#!!0    ( .J!8UL@1B@7KP<
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M7ELNSQ>PNG;60'ZYAW>2/J:,4=$;_/O-??/O=L\;:!&6H9]'>.'V]M[($WR
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M2-*!3Q;G4[6&Z>*NU5%<B!WA8K*L6X'%ZY0P#.WM6Z\**PP7 @0$DE3&Y53
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M;[^\>G;[1?_2___HJV?_ U!+ P04    " #J@6-;5]S7,3P@  "48@$ '
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MZ^Z/I]>K#__3ZX(%:UFG0@+!#X,,ZAW%UK1:!G<I@U<L(9=A+*7O)T,U,^-
MP,W\I*F&3GSXGAL'U_-3]$3QB$9L U=?<V8+SO23* 0+_)'Z #89Z8\82R27
M]):IVCF?O( X-!XI_'_"_DHA)/&!BK'",8D7W &NX+%-S)PT\A(/U(D;_B D
M+ALD^P3:.)>TT]\9QV:MTPAP4 3C 2@:H\/*H=HP"L>$$C%8@XMP!LJ\( GA
M*Q\",Q!J(-\$K@T3O'W,$CH(?<^1J$[ASP-H&%//)><T(&<@^P#=X(<7C>%O
M)/'9R&-#<O$=R,LM]N?AT'-@:+!9V7Q4(F?^.8V( ^O"F,J?XJ/!^2Y 00$
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M^#ZB?\P-<VGHX?ZS %L'1R'OY)/A8H];%WC\5^;+2#]F3E;IRQH$<ZMZSP:
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M 5!+ 0(4 Q0    ( .J!8UMPV/EN=P\  !-H   0              "  0
M  !M960M,C R-3$Q,#,N:'1M4$L! A0#%     @ ZH%C6R84")=W @  ;0@
M !               ( !I0\  &UE9"TR,#(U,3$P,RYX<V102P$"% ,4
M" #J@6-;9#Y-4 0(  "'.0  %               @ %*$@  ;65D+3(P,C4Q
M,3 S7V1E9BYX;6Q02P$"% ,4    " #J@6-;%^B^5^4+  #M9   %
M        @ & &@  ;65D+3(P,C4Q,3 S7VQA8BYX;6Q02P$"% ,4    " #J
M@6-;($8H%Z\'   //   %               @ &7)@  ;65D+3(P,C4Q,3 S
M7W!R92YX;6Q02P$"% ,4    " #J@6-;5]S7,3P@  "48@$ '
M    @ %X+@  ;65D<3,R,#(U96%R;FEN9W-R96QE87-E+FAT;5!+!08
.!@ & (P!  #N3@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>med-20251103_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:exch="http://xbrl.sec.gov/exch/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="med-20251103.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2025-11-03</startDate>
            <endDate>2025-11-03</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-03</startDate>
            <endDate>2025-11-03</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0000910329</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-11-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">MEDIFAST, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-31573</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">13-3714405</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">100 International Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Baltimore</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">21202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">410</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">581-8042</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-13">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-14">MED</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-15">NYSE</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="c-1" id="f-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-17">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
